SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sethi, R.
Right arrow Articles by Dhalla, N. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sethi, R.
Right arrow Articles by Dhalla, N. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Beneficial Effects of Vitamin E Treatment in Acute Myocardial Infarction

Rajat Sethi

Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre

Nobuakira Takeda

Department of Internal Medicine, Aoto Hospital, Jikei University, Tokyo, Japan

Makoto Nagano

Department of Internal Medicine, Aoto Hospital, Jikei University, Tokyo, Japan

Naranjan S. Dhalla

Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada

Background: Vitamin E (Vit E), an antioxidant, is considered to prolong survival in patients and animals after myocardial infarction. Because myocardial infarction is associated with arrhythmia and heart dysfunction, this study tested the hypothesis that early treatment with Vit E reduces mortality because of its protective effects against arrhythmia and cardiac dysfunction induced by acute myocardial infarction.

Methods: Rats were randomly divided into 4 groups: sham control, myocardial infarcted, Vit E-treated sham control, and Vit E-treated infarcted animals. Myocardial infarction was induced by ligation of the left anterior descending coronary artery. Treated animals received Vit E (25 mg/kg/d) through a gastric tube beginning 1 hour after the coronary occlusion, whereas control rats received tap water.

Results: Electrocardiograms (lead II) at 1, 3, 7, and 21 days after coronary occlusion in the untreated animals showed ST-segment elevation, abnormal Q waves, premature ventricular complex (PVC), and QTc prolongation. Conversely, Vit E-treated rats showed attenuated ST-segment changes, fewer abnormal Q waves, and decreased incidence of PVC after coro nary occlusion. Total mortality was reduced from 38% to 16%, whereas the infarct size was decreased from 44.2% to 22.3% in infarcted rats treated with Vit E. The depression in left ventricular function as well as elevation of malondialdehyde content and conjugated diene formation in the 21-day infarcted rat hearts were prevented by Vit E treatment.

Conclusion: These results indicate that Vit E may exert beneficial effects on the heart by reducing oxidative stress in acute myocardial infarction.

Key Words: electrocardiographic changes • myocardial infarction • antioxidants • arrhythmias • heart dysfunction.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 5, No. 1, 51-58 (2000)
DOI: 10.1177/107424840000500107


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. Dreger, K. Westphal, A. Weller, G. Baumann, V. Stangl, S. Meiners, and K. Stangl
Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection
Cardiovasc Res, July 15, 2009; 83(2): 354 - 361.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
R. Sethi, A. Adameova, K. S. Dhalla, M. Khan, V. Elimban, and N. S. Dhalla
Modification of Epinephrine-induced Arrhythmias by N-Acetyl-L-Cysteine and Vitamin E
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 134 - 142.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
H. Dreger, M. Lorenz, A. Kehrer, G. Baumann, K. Stangl, and V. Stangl
Characteristics of Catechin- and Theaflavin-Mediated Cardioprotection
Experimental Biology and Medicine, April 1, 2008; 233(4): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Joyeux-Faure, E. Rossini, C. Ribuot, and P. Faure
Fructose-fed rat hearts are protected against ischemia-reperfusion injury.
Experimental Biology and Medicine, April 1, 2006; 231(4): 456 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Conti, I. M. Renaud, B. Poirier, O. Michel, M.-F. Belair, C. Mandet, P. Bruneval, I. Myara, and J. Chevalier
High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R793 - R800.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. Canbaz, E. Duran, and A. Lassnigg
Ischaemia-reperfusion studies and diabetes mellitus
Br. J. Anaesth., July 1, 2003; 91(1): 158 - 159.
[Full Text] [PDF]



Advertisement